Fresenius Medical Care earnings calendar in focus, shares on the DAX radar
24.06.2026 - 08:13:11 | ad-hoc-news.de
By Mark Bergmann, Earnings & Calendar desk. Reviewed prior to publication on 2026-06-24, 08:08.
Fresenius Medical Care (DE0005785802) sets up the coming quarters with a full earnings calendar as the DAX-listed dialysis group prepares its next reports for Xetra investors. The provider of renal care services remains tied into the broader Fresenius healthcare complex, which also sits in the DAX index alongside other German blue chips.
Upcoming reporting dates and DAX context
Fresenius Medical Care, traded under the ticker FME in Frankfurt and Xetra, typically reports its quarterly figures in early February, May, August and November, giving investors four fixed points per year. The next formal earnings date has not yet been officially fixed on the investor-relations calendar, but the company historically clusters releases around the first week of these months for its annual and quarterly updates according to its prior reporting pattern and DAX practice.
The stock sits in the DAX Performance-Index, which bundles 40 of Germany's largest listed companies, alongside sector-related names such as Fresenius and healthcare peers across medical equipment and services. Analysts and fund managers use these fixed reporting windows to refresh models on Fresenius Medical Care’s revenue from dialysis treatments and products, as well as on operating margin trends and free cash flow generation, positioning the shares against European healthcare benchmarks.
Analyst coverage and consensus picture
On platforms such as Finanzen100, Fresenius Medical Care is grouped under the medical equipment and healthcare segment, with the FME shares referenced against the wider DAX healthcare cohort. MarketScreener and similar aggregation services show that a mix of German and international houses follow the stock, with coverage often including Deutsche Bank, Berenberg and other European brokers that set price targets and rating distributions around neutral to positive, depending on the latest earnings and guidance revisions.
Analyst notes typically focus on Fresenius Medical Care’s sensitivity to reimbursement regimes for dialysis services, cost efficiency in clinic operations and investment levels in new technologies and home dialysis offerings. Third-party commentary from outlets such as Reuters and Handelsblatt periodically highlights the shares when earnings surprise positively or negatively against consensus or when strategic moves at the parent Fresenius SE ripple through its listed dialysis subsidiary, giving DAX investors additional reference points for sector positioning.
All news and analysis on the Fresenius Medical Care shares
Further background, corporate disclosures and intraday price data on Fresenius Medical Care are available in the dedicated topic section and via the company’s investor-relations page.
How Fresenius Medical Care earns money
Fresenius Medical Care generates most of its revenue by providing dialysis treatments in its own clinics worldwide and by selling dialysis products such as hemodialysis machines, dialyzers and disposables. The business model combines long-term treatment contracts with payors and hospitals, clinic network management and manufacturing of equipment and consumables, giving the company a vertically integrated position in renal care.
Where the Fresenius Medical Care shares trade today
The Fresenius Medical Care shares (DE0005785802) trade on Xetra under the ticker FME; at the last available quotation on Finanzen100, the price feed showed a temporary data gap with no current bid and ask in euros, leaving the most recent verifiable level referenced via the prior closing price.
Key data on the Fresenius Medical Care shares
- Company: Fresenius Medical Care AG & Co. KGaA
- ISIN: DE0005785802
- WKN: 578580
- Ticker: FME
- Trading venue: Xetra
- Price (as of last verifiable Xetra quotation): data gap in live feed, prior closing level used as reference in euros
- Market cap: latest available figure not clearly stated in the accessible sources and thus not cited
- Sector / industry: Healthcare - Medical Equipment & Services
- Index membership: DAX Performance-Index
- Next earnings date: not officially scheduled
Disclaimer: This article provides factual information on the Fresenius Medical Care shares and does not contain investment advice, buy or sell recommendations, or proprietary price targets. Investors should base decisions on their own research and, where appropriate, professional counsel.
